STAR-0502

N/A

Report date: 2026/03/20 20:03:07

Base Information

Drug NameSTAR-0502
Drug Alias NameSTAR-0502STAR0502
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein > Fc fusion proteinBiologics > T cell engagers
Mechanisms of ActionImmunologic cytotoxicityCytotoxic T lymphocytes stimulants
TargetsUpdating
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMarengo Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesIpsen SAMarengo Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A